Long-term Outcomes and Prognostic Factors of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma. Nagata K, Sasaki R, Iwatsu S, Fukushima M, et al. Anticancer Res 2022;42:5001-5007.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nagata K, Sasaki R, Iwatsu S, Fukushima M, et al. Long-term Outcomes and Prognostic Factors of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma. Anticancer Res 2022;42:5001-5007.
PMID: 36192013